Related Experiment Video
Updated: Jun 30, 2025
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
FTO in Lung Cancer: Its Progression and Therapeutic Potential
1Geriatrics Respiratory Medicine Department, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Abstract:
One of the most fatal and frequent malignancies on the planet is lung cancer. Its occurrence and development are the results of multifactorial and multigenic interactions. In recent years, RNA N6-methyladenosine transferase (FTO) has gained significant attention in the field of oncology. FTO is the first RNA demethylase to be found to control target mRNA demethylation. The growth, proliferation, and metastasis of tumor cells are greatly influenced by FTO. Recent studies have found that imbalanced m6A methylation regulatory proteins can induce disruption of downstream RNA metabolism, strongly affecting tumor development. This paper provides an overview of the relationship between FTO and lung cancer, discussing the mechanisms by which FTO is involved in lung cancer and its potential clinical applications.
Insights
RNA N6-methyladenosine transferase (FTO) plays a key role in lung cancer development. This review explores FTO
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Lung cancer is a leading cause of cancer mortality worldwide.
- Its development involves complex genetic and multifactorial interactions.
- RNA N6-methyladenosine transferase (FTO) is emerging as a significant factor in cancer research.
Purpose of the Study:
- To provide an overview of the relationship between FTO and lung cancer.
- To discuss the mechanisms underlying FTO's involvement in lung cancer.
- To explore the potential clinical applications of FTO in lung cancer treatment.
Main Methods:
- Literature review of recent studies on FTO and lung cancer.
- Analysis of FTO's role in RNA methylation and metabolism.
- Examination of FTO's influence on tumor cell growth, proliferation, and metastasis.
Main Results:
- FTO, the first identified RNA demethylase, influences target mRNA demethylation.
- Imbalances in m6A methylation regulatory proteins, including FTO, disrupt RNA metabolism.
- FTO significantly impacts tumor cell progression and metastasis in lung cancer.
Conclusions:
- FTO is implicated in the development and progression of lung cancer.
- Understanding FTO's mechanisms offers potential therapeutic targets.
- Further research into FTO's clinical applications is warranted for lung cancer management.
More Related Videos
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...